SWOG clinical trial number
S1912CD

A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)

Closed
Phase
Accrual
100%
Abbreviated Title
CREDIT
Status Notes
This study will be permanently closed to new patient and caregiver accrual, effective December 16, 2024, at 12:00 p.m. Pacific Time.
Activated
07/26/2021
Participants
ALL NCI Community Oncology Research Program (NCORP) Affiliates and Subaffiliates

Research committees

Cancer Care Delivery

Eligibility Criteria Expand/Collapse

Please see Section 5.0 of the S1912CD protocol.

Publication Information Expand/Collapse

2025

Addressing Challenges in Research Aimed at Reducing Financial Toxicity Among Cancer Patients and Caregivers: An Example From the CREDIT Study (SWOG S1912CD)

A Bell-Brown;B Tawfik;B Segarra-Vazquez;T Hopkins;K Watabayashi;P O'Kane;R Carlos;S Langer;J Unger;A Darke;D Hershman;S Ramsey;V Shankaran Cancer Control Jan-Dec:32:10732748251344469

PMid: PMID40384469 | PMC number: PMC12089715

2023

Assessment of Financial Screening and Navigation Capabilities at NCI Community Oncology Clinics

A Bell-Brown;K Watabayashi;D Delaney;R Carlos;S Langer;J Unger;R Vaidya;A Darke;D Hershman;S Ramsey;V Shankaran JNCI Cancer Spectrum Aug 31;7(5):pkad055. doi: 10.1093/jncics/pkad055

PMid: PMID37561111 | PMC number: PMC10471524

Other Clinical Trials

SWOG Clinical Trial Number
S2417CD

A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention called Current Together After Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance
Research Committee(s)
Cancer Care Delivery
Gastrointestinal Cancer
Activated
08/04/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S1703

Randomized trial comparing overall survival of patients monitored with serum tumor marker directed disease monitoring (STMDDM) versus usual care in patients with metastatic hormone receptor positive breast cancer
Research Committee(s)
Cancer Care Delivery
Breast Cancer
Activated
07/16/2018
Accrual
88%
Open
Phase
SWOG Clinical Trial Number
CTSU/EAQ221CD

Improving Medication Adherence in Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP) SWOG Study Champion: Scott Ramsey, M.D., Ph.D. -
Research Committee(s)
Cancer Care Delivery
Open
Phase